Clinical Trials Logo

Metastatic Cervical Cancer clinical trials

View clinical trials related to Metastatic Cervical Cancer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04380805 Completed - Clinical trials for Recurrent Cervical Cancer

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

Start date: July 15, 2020
Phase: Phase 2
Study type: Interventional

This is a Phase 2, global, multicenter, open label, single arm study designed to evaluate the efficacy, safety, tolerability, pharmacokinetic (PK), and immunogenicity of AK104 monotherapy in adult subjects with previously treated recurrent or metastatic cervical carcinoma.

NCT ID: NCT03816553 Completed - Clinical trials for Recurrent Cervical Carcinoma

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Start date: January 19, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to explore the efficacy and safety of SHR-1210 in combination with apatinib in treating patients with metastatic, persistent, or recurrent cervical cancer.

NCT ID: NCT00430781 Completed - Clinical trials for Metastatic Cervical Cancer

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Start date: November 2006
Phase: Phase 2
Study type: Interventional

This study is being conducted to compare the efficacy and safety of pazopanib in combination with lapatinib with that of lapatinib alone or pazopanib alone in subjects with metastatic cervical cancer